Asia Pacific Point-of-care Influenza Diagnostics Market Size & Outlook
Related Markets
Asia Pacific point-of-care influenza diagnostics market highlights
- The Asia Pacific point-of-care influenza diagnostics market generated a revenue of USD 110.8 million in 2024.
- The market is expected to grow at a CAGR of 6.8% from 2025 to 2033.
- In terms of segment, rapid antigen tests (ridt) was the largest revenue generating test type in 2024.
- Biosensor-Based Tests is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
| Market revenue in 2024 | USD 110.8 million |
| Market revenue in 2033 | USD 199.3 million |
| Growth rate | 6.8% (CAGR from 2025 to 2033) |
| Largest segment | Rapid antigen tests (ridt) |
| Fastest growing segment | Biosensor-Based Tests |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Rapid Antigen Tests (RIDT), Molecular Point-of-Care Tests, Biosensor-Based Tests |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 26.7% of the global point-of-care influenza diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 199.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point-of-Care Influenza Diagnostics Market Scope
Point-of-Care Influenza Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fujirebio Diagnostics | View profile | 5001-10000 | Malvern, Pennsylvania, United States, North America | http://www.fdi.com/ |
| Visby Medical | View profile | 101-250 | San Jose, California, United States, North America | https://www.visbymedical.com/ |
| Twist Bioscience Corp | View profile | 919 | 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 | https://www.twistbioscience.com |
| Diasorin SpA | View profile | 3233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | https://www.diasoringroup.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Asia Pacific point-of-care influenza diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care influenza diagnostics market will help companies and investors design strategic landscapes.
Rapid antigen tests (ridt) was the largest segment with a revenue share of 49.28% in 2024. Horizon Databook has segmented the Asia Pacific point-of-care influenza diagnostics market based on rapid antigen tests (ridt), molecular point-of-care tests, biosensor-based tests covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Asia Pacific point-of-care influenza diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific point-of-care influenza diagnostics market databook
-
Our clientele includes a mix of point-of-care influenza diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific point-of-care influenza diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific point-of-care influenza diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific point-of-care influenza diagnostics market size, by country, 2021-2033 (US$M)
Asia Pacific Point-of-Care Influenza Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
